Valuation Zai Lab Limited Deutsche Boerse AG

Stocks

Market Closed - Deutsche Boerse AG Other stock markets 02:08:26 2026-06-19 EDT			5-day change	1st Jan Change
15.40 ^EUR	+0.65%		+6.94%	+5.48%

06-16	Zai Lab Receives EU Orphan Drug Designation for Lung Cancer Drug	MT
06-10	Asian Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	6,059	2,946	2,688	2,853	1,962	2,043	-	-
Change	-	-51.37%	-8.77%	6.15%	-31.23%	4.11%	-	-
Enterprise Value (EV) ¹	4,650	1,938	1,897	2,095	1,397	1,599	1,655	1,828
Change	-	-58.33%	-2.13%	10.47%	-33.34%	14.53%	3.5%	10.43%
P/E	-8.29x	-6.63x	-7.9x	-10.1x	-11x	-8.21x	-9.75x	-13.5x
PBR	4.35x	-	3.34x	3.36x	2.73x	3.83x	4.11x	4.07x
PEG	-	0.2x	0.3x	0.4x	0.3x	-0.2x	0.6x	0.5x
Capitalization / Revenue	42x	13.7x	10.1x	7.15x	4.26x	4.55x	3.43x	2.7x
EV / Revenue	32.2x	9.01x	7.11x	5.25x	3.04x	3.56x	2.78x	2.42x
EV / EBITDA	-6.7x	-4.89x	-5.3x	-7.75x	-6.51x	-6.58x	-10.4x	-27.5x
EV / EBIT	-6.64x	-4.79x	-5.17x	-7.43x	-6.09x	-6.18x	-9.53x	-21.3x
EV / FCF	-8.19x	-4.94x	-9.23x	-9.5x	-8.5x	-9.1x	-14.3x	-26x
FCF Yield	-12.2%	-20.2%	-10.8%	-10.5%	-11.8%	-11%	-7%	-3.84%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-7.58	-4.63	-3.46	-2.6	-1.6	-2.215	-1.865	-1.347
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	144.3	215	266.7	399	460.2	448.7	595.6	755.9
EBITDA ¹	-693.6	-396.1	-357.5	-270.3	-214.4	-243	-159.9	-66.57
EBIT ¹	-700.1	-404.4	-366.6	-282.1	-229.4	-258.7	-173.7	-85.83
Net income ¹	-704.5	-443.3	-334.6	-257.1	-175.5	-240.9	-156.5	-125.8
Net Debt ¹	-1,409	-1,008	-791.3	-757.9	-565.3	-443.1	-387.2	-214.4
Reference price ²	62.85	30.70	27.33	26.19	17.64	18.18	18.18	18.18
Nbr of stocks (in thousands)	96,409	95,972	98,349	108,937	111,219	112,355	-	-
Announcement Date	3/1/22	3/1/23	2/27/24	2/27/25	2/26/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
REGENERON PHARMACEUTICALS, INC.	15.79x	3.41x	9.2x	0.64%	62.05B
UCB	26.92x	5.45x	15.93x	0.59%	54.52B
SAMSUNG BIOLOGICS CO.,LTD.	33.97x	11.5x	21.69x	-.--%	41.55B
CSL LIMITED	-52.51x	3.11x	9.2x	3.5%	39.06B
BIOGEN INC.	31.74x	3.42x	10.51x	-.--%	29.02B
MODERNA, INC.	-7.4x	10.45x	-6.37x	-.--%	25.38B
INCYTE CORPORATION	14.83x	2.6x	8.05x	-.--%	19.62B
INNOVENT BIOLOGICS, INC.	47.78x	5.2x	36.07x	-.--%	16.89B
SWEDISH ORPHAN BIOVITRUM AB	24.64x	5.1x	13.75x	-.--%	15.89B
Average	15.08x	5.58x	13.11x	0.53%	33.78B
Weighted average by Cap.	13.26x	5.57x	12.60x	0.69%